Table 1 Fetal outcome and patient characteristics and medications prior to pregnancy
n = 108 | |
|---|---|
Fetal outcome | |
Live birth, n (%) | 83 (76.9) |
Full-term birth, n (%) | 56 (51.9) |
Preterm birth, n (%) | 27 (25.0) |
Miscarriage, n (%) | 11 (10.2) |
Fetal loss, n (%) | 3 (2.8) |
Elective abortion, n (%) | 11 (10.2) |
Age, years old | 33 (30 - 36) |
SLE duration, years | 8 (4 - 13) |
History of lupus nephritis, n (%) | 29 (26.9) |
SLEDAI, score | 0 (0 - 4) |
Past use of steroid pulse therapy, n (%) | 27 (25.0) |
Past use of IVCY, n (%) | 14 (13.0) |
Prednisolone, n (%) | 91 (84.3) |
Prednisolone dose, mg/day | 10 (5 - 12) |
Azathioprine, n (%) | 23 (21.3) |
Tacrolimus, n (%) | 49 (45.3) |
HCQ, n (%) | 11 (10.2) |
Serum C3 level, mg/dL | 81 (74 - 92) |
Positive Anti-ds-DNA Ab, n (%) | 73 (67.6) |
Anti-dsDNA Ab, IU/ml | 5.1 (2.5 - 8.4) |
Positive anti-Ro/SS-A Ab, n (%) | 38 (35.2) |
Positive LA or anti-aCL-IgG Ab or anti-β2GP1 Ab | 46 (43) |
Positive anti-RNP Ab, n (%) | 35 (32.4) |
Positive anti-Sm Ab, n (%) | 9 (8.3) |